Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-FLUORO-7-HYDROXY-1-INDANONE is a chemical compound belonging to the class of indanones, which are organic compounds containing a 1-indanone moiety. It is a derivative of 1-indanone with a fluorine atom and a hydroxyl group attached to the 4 and 7 positions, respectively. 4-FLUORO-7-HYDROXY-1-INDANONE possesses unique chemical properties and a distinct structure, making it a valuable building block in the synthesis of various biologically active molecules and drugs.

136191-16-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 136191-16-7 Structure
  • Basic information

    1. Product Name: 4-FLUORO-7-HYDROXY-1-INDANONE
    2. Synonyms: 4-FLUORO-7-HYDROXY-1-INDANONE;4-FLUORO-7-HYDROXYINDAN-1-ONE;4-fluoro-7-hydroxy-2,3-dihydro-1H-inden-1-one;4-Fluoro-2,3-dihydro-7-hydroxy-1H-inden-1-one;1H-Inden-1-one, 4-fluoro-2,3-dihydro-7-hydroxy-;4-FLUORO-7-HYDROXY-2,3-DIHYDRO-1H-INDEN-1-ONE(WXC05104)
    3. CAS NO:136191-16-7
    4. Molecular Formula: C9H7FO2
    5. Molecular Weight: 166.15
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 136191-16-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 335.2±42.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.412
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 10.30±0.20(Predicted)
    10. CAS DataBase Reference: 4-FLUORO-7-HYDROXY-1-INDANONE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-FLUORO-7-HYDROXY-1-INDANONE(136191-16-7)
    12. EPA Substance Registry System: 4-FLUORO-7-HYDROXY-1-INDANONE(136191-16-7)
  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 22
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 136191-16-7(Hazardous Substances Data)

136191-16-7 Usage

Uses

Used in Pharmaceutical Industry:
4-FLUORO-7-HYDROXY-1-INDANONE is used as a building block for the synthesis of biologically active molecules and drugs. Its unique chemical properties and structure contribute to the development of new compounds with improved properties, enhancing their therapeutic effects and safety profiles.
Used in Agrochemical Industry:
4-FLUORO-7-HYDROXY-1-INDANONE is used as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure and properties can be utilized to design new compounds with enhanced efficacy and selectivity, improving crop protection and reducing environmental impact.
Used in Research and Development:
4-FLUORO-7-HYDROXY-1-INDANONE is used as a research tool for studying the structure-activity relationship of indanone derivatives. Its unique chemical properties and structure provide valuable insights into the design and optimization of new compounds with improved properties and biological activities.

Check Digit Verification of cas no

The CAS Registry Mumber 136191-16-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,1,9 and 1 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 136191-16:
(8*1)+(7*3)+(6*6)+(5*1)+(4*9)+(3*1)+(2*1)+(1*6)=117
117 % 10 = 7
So 136191-16-7 is a valid CAS Registry Number.

136191-16-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-fluoro-7-hydroxy-2,3-dihydroinden-1-one

1.2 Other means of identification

Product number -
Other names AM732

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:136191-16-7 SDS

136191-16-7Downstream Products

136191-16-7Relevant articles and documents

6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

-

Paragraph 0145-0146; 0289; 0291, (2021/11/14)

A 6-oxo-1,6-dihydropyridazine derivative, a preparation method therefor and medical use thereof, in particular, a 6-oxo-1,6-dihydropyridazine derivative represented by general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivative, and use thereof as a NaV inhibitor and use thereof in the preparation of a drug for the treatment and/or prevention of pain and pain-related diseases. Each substituent in general formula (I) is the same as defined in the description.

Compound and application of compound in preparation of medicines

-

Paragraph 0157; 0158; 0159; 0286, (2016/10/08)

The invention discloses a compound and its application in a medicine. the invention specifically provides a compound as shown in the formula (I) or a stereisomer, a geometrical isomer, a tautomer, a racemate, nitric oxide, hydrate, a solvate, a metabolite, pharmaceutically acceptable salts or a prodrug of the compound as shown in the formula (I). The invention also discloses an application of the compound in preparation of a medicine. The medicine is used in treating cancers.

Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors

Tsukada, Tomoharu,Takahashi, Mizuki,Takemoto, Toshiyasu,Kanno, Osamu,Yamane, Takahiro,Kawamura, Sayako,Nishi, Takahide

scheme or table, p. 1004 - 1007 (2010/06/16)

With the goal of improving metabolic stability and further enhancing FBPase inhibitory activity, a series of tricyclic 8H-indeno[1,2-d][1,3]thiazoles was designed and synthesized with the aid of structure-based drug design. Extensive SAR studies led to th

Bicyclic amino-substituted compounds

-

, (2008/06/13)

A compound of formula (I), wherein X is O, CH 2, S, SO or SO 2 ; R is F or Cl; R 1 is H, C 1 -C 6 alkyl or C 2 -C 6 alkenyl; R 2 is H, C 1 -C 6 alkyl or C 2 -C 6 alkenyl; R 3 is H, C 1 -C 6, alkyl, a pharmaceutically acceptable salt thereof, an enantiomer thereof, and a pharmaceutically acceptable salt of said enantiomer for use in therapy. A pharmaceutical preparation containing as active ingredient any one of said compounds. A process for the preparation of a compound of formula (I).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 136191-16-7